Bol.
Diadin Vet
Generic Drug: Sulfadimidine
View Alternative Brand Names (6)Drug Class: Antibiotic
Manufacturer: Renata Pharmaceuticals Ltd.
Basic information
Presentation and price
5 gm
Dose and dosage
First day: 1bolus/25-50kg body weight
From 2nd day: 1bolus/50-100kg body weight for 4 days.
For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.
First day: 1bolus/25-50kg body weight
From 2nd day: 1bolus/50-100kg body weight for 4 days.
For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.
First day: 1bolus/25-50kg body weight
From 2nd day: 1bolus/50-100kg body weight for 4 days.
For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.
First day: 1bolus/25kg body weight
From 2nd day: 1bolus/50kg body weight for 4 days.
For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.
First day: 1bolus/25kg body weight
From 2nd day: 1bolus/50kg body weight for 4 days.
For Uterine Therapy: 1 bolus directly to the uterus or apply after making powder.
- Pneumonia
- bronchitis
- Hemorrhagic Septicemia
- Actinobacillosis
- infection of urogenital system
- Metritis
- Retention of placenta
- Abscess
- Gastrointestinal infection
- Diarrhea
- Dysentery
- Enteritis
- salmonellosis
- Septicemia
Prevention of secondary bacterial infection
- Hypersensitivity
N/A
Sulfadimidine is a short-acting sulfonamide. It interferes with the synthesis of nucleic acids in sensitive organisms by blocking the conversion of p-aminobenzoic acid (PABA) to the co-enzyme dihydrofolic acid.
Nausea, vomiting, anorexia, diarrhoea, hypersensitivity reactions, SLE, serum sickness-like syndrome, liver necrosis and hepatomegaly, myocarditis, pulmonary eosinophilia and fibrosing alveolitis, vasculitis, hypoglycaemia, hypothyroidism, neurological reactions, jaundice and kernicterus in premature neonates
Sulfadimidine has been assigned to pregnancy category C by the FDA. Sulfonamides cross the placenta. Animal studies with high oral doses of some sulfonamides have revealed an increased incidence of cleft palate and other bony abnormalities.
Because sulfonamides compete with bilirubin for binding to serum albumin, free bilirubin levels rise in the presence of sulfonamides. Neonates are, therefore, at risk for hyperbilirubinemia, jaundice, and kernicterus when sulfonamides are administered to the mother near term
Meat: 7 days
Milk: 3 days